Component

Meloxicam

Meloxicam. Species, exposure and limitations are retained in each linked claim.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

Where it participates (unsigned role)

  1. Measurement of the inhibitory potency of non-steroidal anti-inflammatory drugs on cyclooxygenase isoforms is strongly influenced by variations in experimental conditions, the concentration of protein in the assay medium being particularly important because these drugs are highly protein bound in vivo so that assays based on human whole blood provide the most suitable test system, and of the drugs investigated only meloxicam showed selectivity for cyclooxygenase-2 at therapeutically relevant concentrations while standard drugs such as naproxen inhibited both isoforms to an equal degree.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/ibuprofen-research/9219317.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d3edafe44ec9bf9e15505ffebb96add5467f8874fe8b585ce3878c473f250714", "start_char": 0, "end_char": 1162, "text_sha256": "d3edafe44ec9bf9e15505ffebb96add5467f8874fe8b585ce3878c473f250714"}
    experimental_model
    Comparison of cyclooxygenase inhibitory potency across assay systems, using the human whole blood assay
    exposure
    Standard non-steroidal anti-inflammatory drugs compared at therapeutically relevant concentrations
    limitations
    Argues that the whole blood assay is the appropriate test because these drugs are highly protein bound. It reports conclusions about the class, with naproxen named rather than ibuprofen.
    nutrient_topic
    Ibuprofen research collection; topical membership is not evidence of a direct clinical effect, and the racemate is recorded separately from each of its two enantiomers. · Ibuprofen
    organism
    Human
    plain_language
    Measured in blood rather than in a tube of enzyme, the ordinary anti-inflammatories hit both enzymes about equally.
    primary_references
    [ibu-p9219317] Differentiating among nonsteroidal antiinflammatory drugs by pharmacokinetic and pharmacodynamic profiles. (1997). https://pubmed.ncbi.nlm.nih.gov/9219317/ DOI: 10.1016/s0049-0172(97)80050-9
    tissue_or_cell_type
    Whole blood

    Ibuprofen: the enantiomer that works, the one that was called inactive, the one-way chemistry that turns one into the other, and the targets that are not cyclooxygenase (2026-09-22) · lines 344–355

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Comparison of cyclooxygenase inhibitory potency across assay systems, using the human whole blood assay · source_derived_draft · unverified_draft

    ### ibu-no-selectivity-in-whole-blood Measurement of the inhibitory potency of non-steroidal anti-inflammatory drugs on cyclooxygenase isoforms is strongly influenced by variations in experimental conditions, the concentration of protein in the assay medium being particularly important because these drugs are highly protein bound in vivo so that assays based on human whole blood provide the most suitable test system, and of the drugs investigated only meloxicam showed selectivity for cyclooxygenase-2 at therapeutically relevant concentrations while standard drugs such as naproxen inhibited both isoforms to an equal degree. Condition category: normal nutrient_topic: Ibuprofen research collection; topical membership is not evidence of a direct clinical effect, and the racemate is recorded separately from each of its two enantiomers. plain_language: Measured in blood rather than in a tube of enzyme, the ordinary anti-inflammatories hit both enzymes about equally. organism: Human tissue_or_cell_type: Whole blood experimental_model: Comparison of cyclooxygenase inhibitory potency across assay systems, using the human whole blood assay limitations: Argues that the whole blood assay is the appropriate test because these drugs are highly protein bound. It reports conclusions about the class, with naproxen named rather than ibuprofen. exposure: Standard non-steroidal anti-inflammatory drugs compared at therapeutically relevant concentrations evidence_span: {"source_cache": "artifacts/ibuprofen-research/9219317.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "d3edafe44ec9bf9e15505ffebb96add5467f8874fe8b585ce3878c473f250714", "start_char": 0, "end_char": 1162, "text_sha256": "d3edafe44ec9bf9e15505ffebb96add5467f8874fe8b585ce3878c473f250714"} [ibu-p9219317] Differentiating among nonsteroidal antiinflammatory drugs by pharmacokinetic and pharmacodynamic profiles. (1997). https://pubmed.ncbi.nlm.nih.gov/9219317/ DOI: 10.1016/s0049-0172(97)80050-9
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards